Start for free
Start for free
6C

683 CAPITAL

North America, New York, United States, New York

Description

683 CAPITAL MANAGEMENT is a hedge fund.

Investor Profile

683 CAPITAL has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (75%)
  • Series B (13%)
  • Series C (13%)

Country Focus

  • United States (75%)
  • Germany (13%)
  • Switzerland (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Life Science
  • Therapeutics
  • Oncology
  • Genetics
  • Service Industry
  • Neuroscience
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 683 CAPITAL frequently co-invest with?

EcoR1 Capital
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
Wellington Management
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 3
Samsara BioCapital
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 4
Bain Capital Life Sciences
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 3
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 3
Armistice Capital
Armistice Capital
North America, New York, United States, New York
Co-Investments: 2
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

Which angels does 683 CAPITAL often collaborate with?

BT
Belinda Termeer
North America, Massachusetts, United States, Marblehead
Shared Deals: 1

What are some of recent deals done by 683 CAPITAL?

Leap Therapeutics

Cambridge, Massachusetts, United States

Leap Therapeutics is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.

BiotechnologyLife ScienceMedicalOncology
Post Ipo EquityApr 10, 2024
Amount Raised: $40,000,000
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquityOct 10, 2022
Amount Raised: $110,000,000
MoonLake Immunotherapeutics

Zug, Zug, Switzerland

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Biotechnology
Post Ipo EquityApr 6, 2022
Amount Raised: $115,000,000
2seventy bio

Cambridge, Massachusetts, United States

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Post Ipo EquityMar 16, 2022
Amount Raised: $170,000,000
Renovacor

Philadelphia, Pennsylvania, United States

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

BiotechnologyHealth CareLife Science
Post Ipo EquitySep 3, 2021
Amount Raised: $30,000,000
Amylyx Pharmaceuticals

Cambridge, Massachusetts, United States

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

BiotechnologyMedicalNeurosciencePharmaceutical
Series CJul 20, 2021
Amount Raised: $135,000,000
Tvardi Therapeutics

Houston, Texas, United States

Tvardi Therapeutics is a Private, Clinical Stage Biotechnology Company.

BiotechnologyHealth CarePharmaceuticalService Industry
Series BJun 15, 2021
Amount Raised: $72,418,254
Nuvation Bio

New York, New York, United States

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityFeb 11, 2021
Amount Raised: $502,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator